Sort
23,748 grants matching “melanoma”
Penn Small Animal Imaging Resource (Penn-SAIR)
$456,252Jerry D Glickson · University Of Pennsylvania · U24 · FY2009 · CA
Project 1: Nanotherapies for Vemurafenib Resistant Melanoma
$456,006Leaf Huang · Univ Of North Carolina Chapel Hill · U54 · FY2018 · CA
Project 1: Nanotherapies for Vemurafenib Resistant Melanoma
$456,006Leaf Huang · Univ Of North Carolina Chapel Hill · U54 · FY2015 · CA
Promoting tumor cell apoptosis by death ligands
$455,987Thomas Sayers · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Novel Potent Autophagy Inhibitors for Melanoma
$455,948Jeffrey D Winkler · Wistar Institute · P01 · FY2016 · CA
IDENTIFICATION OF MELANOMA PREDISPOSITION LOCI
$455,921University Of Utah · R01 · FY2003 · CA
Novel Potent Autophagy Inhibitors for Melanoma
$455,888Jeffrey D Winkler · Wistar Institute · P01 · FY2017 · CA
Melanoma: Metabolic Biomarkers of Response to Targeted Therapy
$455,881Kavindra Nath · University Of Pennsylvania · R01 · FY2024 · CA
Modulation of asparagine bioavailability and stress response signaling to enhance T cell robustness and maximize immunotherapy
$455,851Ruoning Wang · Research Inst Nationwide Children'S Hosp · R01 · FY2024 · CA
Hemodynamic Noninvasive Skin Cancer Diagnostics
$455,835Mirianas Chachisvilis · Veriskin, Inc. · R44 · FY2016 · CA
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
$455,723Niroshana Anandasabapathy · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · AR
Suppression of Melanoma Initiation and Progression by NM23-H1
$455,663David M Kaetzel · University Of Maryland Baltimore · R01 · FY2013 · CA
Targeting HSP70 for MelanomaTherapy
$455,537Maureen E Murphy · Wistar Institute · P01 · FY2022 · CA
Targeting macrophages in metastatic cancer
$455,525Anthony Rongvaux · Fred Hutchinson Cancer Research Center · R01 · FY2021 · CA
Discovery of chemical probes for uveal melanoma
$455,506Erwin G Van Meir · Emory University · R01 · FY2013 · CA
An innate immune checkpoint in cancer immunotherapy
$455,406Carla Rothlin · Yale University · R01 · FY2017 · CA
Resolving Spatiotemporal Dynamics of Recombinant Poliovirus Immunotherapy
$455,171Matthias Gromeier · Duke University · R01 · FY2025 · CA
Neoadjuvant immunotherapy approaches to early stage melanoma
$455,161Meenhard Herlyn · Wistar Institute · P50 · FY2024 · CA
Endothelial Transdifferentiation of Invasive Tumor Cells
$455,000Children'S Memorial Hospital (Chicago) · R37 · FY2004 · CA
A democratized platform for mapping the spatial epigenome in tissue
$454,975Jeffrey Sabina · Atlasxomics Inc. · R44 · FY2024 · CA
TRANSLATIONAL CLINICAL TRIALS FOR PRIMARY CNS TUMORS
$454,899David Reardon · Duke University · P50 · FY2009 · NS
RasGRP3 and Protein Kinase D as therapeutic targets for Uveal Melanoma
$454,865Xu Chen · University Of California, San Francisco · R01 · FY2025 · CA
INTEGRINS AND OCULAR ANGIOGENESIS
$454,760Scripps Research Institute · R01 · FY2004 · EY
RasGRP3 and Protein Kinase D as therapeutic targets for Uveal Melanoma
$454,716Xu Chen · University Of California, San Francisco · R01 · FY2023 · CA
CONFORMAL RADIOACTIVE PLAQUES FOR INTRAOCULAR MELANOMA
$454,658Radiomed Corporation · R44 · FY2000 · EY